Financial Review: ELEKTA AB/ADR (OTCMKTS:EKTAY) versus CBA Florida (CBAI)

CBA Florida (OTCMKTS:CBAI) and ELEKTA AB/ADR (OTCMKTS:EKTAY) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations and institutional ownership.

Profitability

This table compares CBA Florida and ELEKTA AB/ADR’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
CBA Florida N/A -27.39% -23.92%
ELEKTA AB/ADR 9.35% 16.86% 5.47%

Valuation & Earnings

This table compares CBA Florida and ELEKTA AB/ADR’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
CBA Florida N/A N/A $13.17 million N/A N/A
ELEKTA AB/ADR $1.37 billion 3.16 $132.53 million $0.35 33.43

ELEKTA AB/ADR has higher revenue and earnings than CBA Florida.

Insider & Institutional Ownership

0.0% of ELEKTA AB/ADR shares are held by institutional investors. 30.0% of CBA Florida shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Volatility and Risk

CBA Florida has a beta of -0.44, indicating that its stock price is 144% less volatile than the S&P 500. Comparatively, ELEKTA AB/ADR has a beta of 0.52, indicating that its stock price is 48% less volatile than the S&P 500.

Dividends

ELEKTA AB/ADR pays an annual dividend of $0.10 per share and has a dividend yield of 0.9%. CBA Florida does not pay a dividend. ELEKTA AB/ADR pays out 28.6% of its earnings in the form of a dividend.

Analyst Ratings

This is a summary of recent ratings and price targets for CBA Florida and ELEKTA AB/ADR, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CBA Florida 0 0 0 0 N/A
ELEKTA AB/ADR 0 0 1 0 3.00

Summary

ELEKTA AB/ADR beats CBA Florida on 9 of the 11 factors compared between the two stocks.

CBA Florida Company Profile

CBA Florida, Inc. does not have significant operations. Previously, the company provided umbilical cord blood and cord tissue stem cell processing and storage to families in the United States. The company was formerly known as Cord Blood America, Inc. and changed its name to CBA Florida, Inc. in May 2018. CBA Florida, Inc. is headquartered in Las Vegas, Nevada.

ELEKTA AB/ADR Company Profile

Elekta AB (publ) provides equipment and software for cancer and brain disorders worldwide. The company offers radiotherapy systems under the Versa HD, Precise Treatment System, and Elekta Compact names; Elekta Infinity, an image-guided radiation therapy (IGRT) system; and Elekta Synergy, a digital accelerator for advanced IGRT. It also provides personalized imaging tools; automation and integration systems; beam shaping solutions; patient positioning and immobilization solutions; and radiotherapy treatment planning systems. In addition, the company offers radiosurgery systems under the Leksell Gamma Knife Icon, Leksell Gamma Knife Perfexion, and Elekta Axesse names; Leksell GammaPlan, a treatment planning software; and Elekta Unity, a magnetic resonance radiation therapy solution. Further, it provides care management software, such as MOSAIQ Radiation Oncology and MOSAIQ Medical Oncology; MOSAIQ IQ Scripts, a workflow automation and customization tool; Patient Engagement, a patient communication tool; MOSAIQ Evaluate, a plan management and dose review solution; MOSAIQ Locate, a stereotactic localization solution; and METRIQ, a cancer registry data management solution. Additionally, the company offers Flexitron, a remote after loading platform; microSelectron, a digital pulsed dose rate platform; Esteya, an electronic brachytherapy for treating skin cancer; Oncentra Brachy, a treatment planning software; real-time prostate solutions; and gynecological brachytherapy, bronchus and esophagus, breast, prostate, rectum and bladder, and skin applicators, as well as brachytherapy needles and flexible implant tubes. It also provides Leksell Vantage Stereotactic System for neuroimaging and treatment; Elekta Neuromag TRIUX, a magnetoencephalography system; Leksell Stereotactic System for minimally invasive stereotactic neurosurgery; and proton therapy components. The company was founded in 1972 and is headquartered in Stockholm, Sweden.

Receive News & Ratings for CBA Florida Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CBA Florida and related companies with MarketBeat.com's FREE daily email newsletter.